Alta Life Sciences

Alta Life Sciences operates as a premier multistage venture capital firm specializing in life sciences investments across various development phases. From initial seed funding to commercial expansion, the firm maintains a comprehensive investment approach that encompasses biotechnology, medical devices, diagnostics, genomics, and digital health sectors. Functioning as a transatlantic bridge, Alta LS connects Spain's burgeoning life sciences ecosystem with the established venture capital expertise found in Silicon Valley, creating unique cross-continental opportunities for portfolio companies.

The firm is strategically headquartered in Barcelona and led by Guy Nohra, whose distinguished background includes co-founding Alta Partners, a pioneering venture capital organization in the life sciences sector. Under Nohra's leadership, Alta Partners has provided funding to more than 150 companies since its establishment in 1996, demonstrating a consistent track record of identifying promising opportunities in the healthcare innovation landscape. Nohra's exceptional dealmaking abilities earned him recognition on the prestigious Forbes Midas List in 2007, highlighting his talent for generating significant returns on investments.

Alta Life Sciences has assembled a diverse team comprising experienced life science professionals from both the United States and Spain, creating a unique blend of international expertise and perspectives. This multinational approach allows the firm to leverage deep industry knowledge across different markets while identifying emerging trends and opportunities in the global life sciences sector. The team's combined experience spans decades of investment activity, scientific research, and commercial development, positioning Alta LS to provide substantial value beyond capital to its portfolio companies.

The investment strategy at Alta LS emphasizes flexibility across the funding spectrum, allowing the firm to support companies from their earliest conceptual stages through to market expansion. This stage-agnostic approach enables long-term partnerships with promising ventures as they evolve and mature. The firm operates with Altamar Private Equity, SGIIC, SAU serving as its management company, providing institutional infrastructure and governance. With its combination of deep sector expertise, international perspective, and flexible investment mandate, Alta Life Sciences has established itself as a significant player in the global life sciences investment landscape.